Fig. 1.
Fig. 1. Flow cytometric histograms of bcl-2 and bax expressions on 3 AML samples. / AML cases were analyzed by flow cytometry after exposure to anti-CD33 PE and anti–bcl-2 FITC or bax MoAbs, as described. (A) Bivariate histogram FSC/SSC with “blast gate” on leukemic cells and IgG1 isotype-negative controls for bcl-2 (B) or bax (C) and CD33 MoAbs from “blast gate.” Bcl-2 (Di, Ei, Fi) and bax (Gi, Hi, Ii) were evaluated on the CD33+ cells segregated by “AML cells” gate in 3 AML cases. Bcl-2 (Dii, Eii, Fii) or bax (Gii, Hii, Iii) univariate histograms, conditioned on “AML cells” gate, show the distribution of fluorescence, reported as arithmetic means (M).

Flow cytometric histograms of bcl-2 and bax expressions on 3 AML samples.

AML cases were analyzed by flow cytometry after exposure to anti-CD33 PE and anti–bcl-2 FITC or bax MoAbs, as described. (A) Bivariate histogram FSC/SSC with “blast gate” on leukemic cells and IgG1 isotype-negative controls for bcl-2 (B) or bax (C) and CD33 MoAbs from “blast gate.” Bcl-2 (Di, Ei, Fi) and bax (Gi, Hi, Ii) were evaluated on the CD33+ cells segregated by “AML cells” gate in 3 AML cases. Bcl-2 (Dii, Eii, Fii) or bax (Gii, Hii, Iii) univariate histograms, conditioned on “AML cells” gate, show the distribution of fluorescence, reported as arithmetic means (M).

Close Modal

or Create an Account

Close Modal
Close Modal